Dr. Cesar Fuziwara, MSc and PhD, is a FAPESP Young Investigator at the Institute of Biomedical Sciences of the University of Sao Paulo (ICB/USP). He was a postdoc at ICB/USP and the University of California Berkeley, and his research involves the study of the role of noncoding RNAs, such as microRNAs and lncRNAs, as modulators of oncogenesis and progression of thyroid and lung cancer. Moreover, he investigates the role of epigenetic alterations such as those related to the complex PRC2/EZH2 in aggressive cancer. In terms of methods, he seeks to implement and spread the use of methodologies of gene editing with CRISPR/Cas9 and its variants such as Cas9n and dCas9 to modulate the expression of coding and noncoding genes. He is a recipient of the LATS Young Investigator Award in 2015 at the International Thyroid Congress.